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ABSTRACT
Advances in the nanotechnology research have provided a new set of research tools, materials, structures, and
systems for biological and medical research and applications. These nanotechnologies include the application
of fluorescent quantum dots for optical imaging, the design of metallic nanoparticle surfaces for ultrasensitive
biomolecular fingerprinting, and the use of nanostructures as hyperthermia agents for cancer therapy. Unlike
conventional technologies, unique properties can be incorporated into nanometer-size particles, structures,
and systems simply by changing their size, shape, and composition. Because of the tunable properties,
biologists and clinicians could custom-design a material for a specific research need. In this review article, we
highlight the recent advances and progress in Bionanotechnology research as well as provide future perspective
on this integrative field.
© 2006 American Society for Blood and Marrow Transplantation
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bNTRODUCTION
Nanotechnology has rapidly emerged as an impor-
ant ﬁeld of research with potential effects in both
iagnostics and therapeutics. Nanotechnology is also
xpected to accelerate fundamental biomedical re-
earch via the creation of novel state-of-the-art tools.
e loosely deﬁne nanotechnology research as the crea-
ion, design, and manipulation of structures or parti-
les with dimensions smaller than 100 nm. Within this
ize range, the structures or particles have properties
hat can be tuned by changing the material’s dimen-
ions [1,2] (Figure 1). For example, the ﬂuorescence
mission of CdSe semiconductor particles is depen-
ent on its size; a 2-nm particle emits blue light,
hereas a 6-nm particle emits a red light. Nanotech-
ology research has traditionally been a major focus of
esearch by engineers and physical scientists because
anomaterials were considered as important compo-
ents in the construction of electronic components
nd computer chips. The development of synthetic
rotocols to reproducibly make nanomaterials and to
lucidate the relationship between their properties
ith respect to size and shape is a common area of
esearch. However, in the last 10 years, the biological
nd medical research communities have exploited the
nique properties of nanomaterials for various appli-
ations (eg, contrast agents for cell and animal imag- v
B&MTng and therapeutics for treating cancer), and, because
f these demonstrations, new avenues and promises
ave been created for nanotechnology research.
erms such biomedical nanotechnology, bionanotechnol-
gy, and nanomedicine are used to describe this hybrid
eld.
There seems to be a natural ﬁt between nanotech-
ology and biology. With nanotechnology, a large set
f materials with distinct properties (optical, electrical,
r magnetic) can be fabricated. Functionalities can be
dded to nanomaterials by interfacing them with bio-
ogical molecules or structures (Figure 2). For exam-
le, magnetic nanoparticles with the conjugation of
he antibody Herceptin onto the surface can be used
s a contrast agent for tumor imaging (the antibody
irects the magnetic nanoparticle to the tumor cells
hile the magnetic nanoparticle provides a signal for
ndicating detection) [3]. Diverse and large libraries of
iological molecules, such as antibodies and oligonu-
leotides, are available because they can be produced
y using molecular biology or automated synthetic
echniques. Furthermore, the size of nanomaterials is
imilar to that of most biological molecules and struc-
ures; therefore, nanomaterials can be useful for both in
ivo and in vitro biomedical research and applications.
Thus far, the integration of nanomaterials with
iology has led to the development of diagnostic de-
ices, contrast agents, analytical tools, therapy, and
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8rug-delivery vehicles. Mirkin et al. [4,5] exploited the
ggregation-based absorbance properties of gold nano-
tructures for detecting genetic mutations; Kim et al.
6] developed quantum dots (QDs) for sentinel lymph
ode mapping; Han et al. [7] developed optical bar-
odes for the high-throughput analysis of proteins and
enes; and Hirsch et al. [8] developed metallic nano-
tructures for treating cancer. Although these re-
earchers demonstrated some interesting applications
f nanomaterials, bionanotechnology research is still
n its infancy; few nanotechnology-based products are
n clinical use.
Visionaries in the ﬁeld have predicted that one
ay, researchers will incorporate multifunctionality
nto nanomaterials. With these multifunctional nano-
evices, molecules and motors will guide nanomaterial
ovements, sensors for diagnosis, actuators (which
re connected to the sensor) to release therapy, and a
econdary sensor to monitor the disease as it is being
reated. Such a device can diagnose, treat, and monitor
iseases such as cancer and Alzheimer disease. This
dvancement will likely take at least 50 to 100 years to
evelop. The foundation of nanotechnology is quickly
eing put into place, and some applications of nano-
echnology in biology have surfaced (although these
pplications are nowhere near the complexity of the
escribed multifunctional device). In this article, we
rovide examples of current state-of-the-art bionano-
echnology research.
EMICONDUCTOR QDS FOR BIOIMAGING
Recent developments in the ﬁeld of nanotechnol-
gy have led to the fabrication of a new generation of
igure 1. Rayleigh light-scattering of metallic nanostructures of
ifferent sizes and shapes. This example shows the simplicity of
reating structures with unique properties, simply by changing the
tructure’s dimensions. Adapted with permission [1] from the
merican Association for the Advancement of Science, © 2001.norganic nanostructures that overcome many of the A
8roblems associated with organic-based probes [9].
hese nanometer-sized probes provide novel and unique
roperties for biological applications that are not avail-
ble with organic-based ﬂuorophores. At the forefront of
his new class of inorganic probes are semiconductor
anocrystals, also known as QDs. The physical proper-
ies and applications of QDs have been heavily investi-
ated in many physics and engineering laboratories
ince the early 1980s [10-12]. QDs are deﬁned as
articles with physical dimensions smaller than the
xciton Bohr radius; this gives rise to a unique phe-
omenon known as quantum conﬁnement. Quantum
onﬁnement, which refers to the spatial conﬁnement
f charge carriers (ie, electrons and holes) within a
aterial, embarks QDs with unique optical and elec-
ronic properties that are unavailable to semiconduc-
ors in bulk solids. Although initial interest in QDs
ocused in physical applications (eg, making computer
hips and light-emitting diodes), recent work by Nie,
livisatos, and their coworkers has highlighted the great
romise of QDs in biological applications [13,14]. As
iological probes, QDs are extremely bright (1 QD 
igure 2. Schematics of nanostructures integrated with biological
olecules and structures. A, Schematic of a semiconductor nano-
tructure called quantum dots (sphere) with a protein on its surface.
his quantum dot/protein system can be used for labeling cells,
iosensing, or detecting tumors. Adapted with permission [10] from
he National Academy of Sciences, © 2004. B, Schematic of a nickel
anostructure bound to an F1-adenosine triphosphatase biomolecular
otor. The motor is a mechanical device to power up and direct the
anostructure. One day, these motors may be important components
n building nanodevices for in vivo biomedical applications such as
ancer treatment. Adapted with permission [20] from the American
ssociation for the Advancement of Science, © 2000.
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B0-20 organic ﬂuorophores), have high resistance to
hotobleaching, have narrow spectral line widths, and
ave size- and materials-tunable emission that can be
xcited by using a single wavelength. When QDs are
sed in biological research and applications, these op-
ical properties will lead to improved detection sensi-
ivity for analysis and to simpliﬁcation in experimental
nd instrumental design. Because QDs have ﬂuores-
ence properties, they have been rapidly adapted into
any biological and medical research laboratories.
or in vitro applications, QDs conjugated to antibod-
es and peptides are used for labeling receptors on
xed and live cells and tissues; QDs conjugated to
ligonucleotides are used for genetic detection. For in
ivo applications, successful demonstration of QDs as
ontrast agents for cancer imaging has already been
chieved. Kim et al. [6], Akerman et al. [15], and Gao
t al. [16] have all shown the accumulation of QDs in
nimal tumors.
As QDs advance, there are several major avenues
f research. The ﬁrst is the continuing improvement
nd development of QD optical probes with better
ptical qualities (ie, high quantum efﬁciencies, narrow
pectral line widths, and more brightness). The sec-
nd is to understand the relationship between QDs
nd biological systems (ie, elucidating how cells and
nimals uptake, process, and metabolize QDs). The
hird is to study and understand the inﬂuence of bio-
ogical environments and conditions on the optical
nd electronic properties of QDs. The fourth is to
pply QDs toward clinical applications.
ETALLIC NANOSTRUCTURES AS SENSORS
Many reports on the biological applications of
etallic nanostructures as biological sensors have re-
ently surfaced. Unlike QDs, metallic nanostructures
ere incorporated or used in many biomedical appli-
ations in the 1970s and 1980s [17,18]. Gold nano-
tructures are used as contrast agents in electron mi-
roscopy or as detection probes for dipsticks (such as
hose for pregnancy tests). The manipulation of the
ize, shape, and aggregation-dependent absorbance
roperties of metallic nanostructures and their dem-
nstrated applications have made this one of the most
xciting areas of bionanotechnology research.
The absorbance and scattering of light by metallic
anostructures is size and aggregation dependent
1]. A solution of gold nanostructures appears ruby
ed, but the color of solution changes to blue when
he gold nanostructures are in close contact to one
nother (or are aggregated). In this colorimetric
iagnostic system, the biorecognition molecule oli-
onucleotide (which recognizes a gene for a speciﬁc
isease) is coated onto the surface of the gold nano-
tructure. When a gene sequence matches the oli- s
B&MTonucleotide sequence on the gold, hybridization
ccurs. With hybridization, the nanostructures are
rought close together, and the solution color
hanges (as an indicator of detection). This diagnos-
ic system has advanced toward a surface platform,
here silver staining is used for ampliﬁcation of signal.
Metallic nanostructures can also be a platform for
urface-enhanced Raman spectroscopy (SERS). Ra-
an spectroscopy is an analytical technique that mea-
ures the vibrational frequencies of chemical bonds
pon optical excitation. The major advantage of Ra-
an spectroscopy is that a tag or label is not required
or detection, but the technique is less sensitive than
uorescence. However, the adsorption of molecules
nto roughened metallic surfaces enhances the detec-
ion capability of Raman spectroscopy. This technique
s called SERS. Emory and Nie [19] showed that
ERS could detect a single molecule if that molecule
as adsorbed onto a metallic nanostructure with a
ensitivity comparable to that of ﬂuorescence. SERS is
tarting to emerge as a viable analytical technique for
linical detection.
Therapeutic applications of metallic nanostruc-
ures are also possibilities. Photothermal properties
an be engineered into the metallic nanostructures for
aser ablation therapy. Metallic nanoshells, where a
anometer-sized metallic layer is grown onto a glass
ead’s surface, and rods, where the nanoparticle’s as-
ect ratio is greater than 1:1, will produce heat when
lluminated with a light source (that matches the
anostructure’s surface plasmon resonance). The sur-
ace plasmon resonance is deﬁned as a packet of elec-
rons on the surface of the metallic nanoparticle that
ecomes excited after optical illumination. These me-
allic structures can be used for hyperthermia therapy.
We have highlighted some of the emerging appli-
ations of metallic nanostructures. There are, however,
any other applications (eg, molecular rulers and drug
elivery) for metallic nanostructures.
THER NANOSTRUCTURES
In addition to QDs and metallic nanostructures,
ther nanostructures have been synthesized and used
n biological and medical research. Among these
anostructures are carbon nanotubes, fullerenes, den-
rimers, and magnetic nanostructures. Thus far, they
ave found applications in imaging (as contrast agents
r surface probe tips), drug delivery, and biosensing.
OWARD FUNCTIONAL DEVICES: INTEGRATION OF
ANOSTRUCTURES WITH BIOLOGICAL MOLECULES
ND STRUCTURES
With recent advances in the synthesis of nano-
tructures and a demonstration of their utility in bio-
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9edical research, a major focus of the nanotechnology
ommunity is on the design of multifunctional nano-
evices. These devices will be a new type of advanced
herapy for the treatment of cancer, Alzheimer dis-
ase, or infections. Two major questions arise: (1)
ow can one organize nanostructures into a func-
ional device? and (2) How can one control the func-
ion of these nanostructures? Toward the engineering
f these nanodevices, researchers use biology as an
nspiration. Biological molecules and structures are
sed for organizing nanostructure aggregations; bio-
ogical motors are incorporated into the design to
reate rotors to control the nanostructure’s move-
ents. Currently, it is not clear how an engineer will
dd sensing and actuating capability into the nano-
tructures.
The mimicking of biological systems for designing
anodevices may be a powerful strategy. In biological
ystems, only 20 amino acids and 4 bases are needed to
oordinate the functions of thousands of proteins. The
mino acids and bases can assemble useful biological
tructures with noncovalent interactions. These inter-
ctions include hydrophobic-hydrophobic interactions,
an der Waals forces, hydrogen bonding, and molecular
tacking. Nanostructures, in general, are highly depen-
ent on molecular forces to assist them in maintaining
heir monodispersity. Coordinating molecular forces,
hich are used to fold proteins into a functional unit,
nto the surface of nanostructures is currently difﬁcult
ecause protein-folding mechanisms remain some-
hat unclear. A simpler and ﬁrst step toward the use
f biology to mediate nanoparticle assembly is the
se of biorecognition molecules. Biorecognition
olecules can be coated onto a nanoparticle surface
o direct the formation of aggregates.
The simple mixing of antibody-coated nanostruc-
ures with their matching antigen in aqueous solution
an lead to rapid aggregation of nanostructures. For
xample, proteins such as avidin have 4 binding sites
o the small organic molecule biotin; antibodies have
n inhomogeneous structure with a total of 3 binding
ites. These 2 protein systems can coordinate the
verall shape, size, and nanoparticle spacing of the
ggregate network. For nanoparticle assembly, pro-
eins may act as “molecular glue.” Oligonucleotides
re also being used to assemble nanostructures. They
rovide great versatility in the assembly process. Oli-
onucleotides are short fragments of DNA or RNA
hat can be easily synthesized by using a machine.
imilar to a zipper, single-stranded oligonucleotide
equences hybridize, or pair up, with a matching se-
uence via hydrogen-bonding interactions. They
ehybridize simply by heating. To make nanopar-
icle assembly dynamic (or responsive nanodevices),
ore complex molecular glue may be needed be-
ause some protein-protein interactions are essen-
ially irreversible (eg, streptavidin-biotin).
0To add functionality into the nanostructures,
oong et al. [20] coated the surface of inorganic nano-
tructures with biomolecular motors, such as F1-aden-
sine triphosphate synthase. This molecular motor
ropelled the particles in solution. Hess et al. [21]
roposed the use of motor proteins with microtubule
rack systems to construct molecular conveyer belts to
uild nanoscale devices. They mimicked the biological
rocess of vesicle transport inside cells.
ONCLUSIONS
We have highlighted some of the recent develop-
ents in bionanotechnology research and provided
ome insights into the future of this hybrid ﬁeld. As
he ﬁeld of bionanotechnology evolves, we envision a
rend toward clinics, because nanotechnology will
ikely allow a clinician to diagnose diseases at faster
ates with improved sensitivity and speciﬁcity. The
ore futuristic goals of bionanotechnology, such as
ultifunctional nanodevices, will take much longer to
evelop. Researchers are now starting to ﬁgure out
ow to build such devices. This emerging ﬁeld is
xciting because of its possibilities.
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